A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).

HOME
>
論文・技術情報
>
A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).

アブストラクト
ジャーナル名	Drug safety
投稿日	2020/4/6
投稿者	Rees, Kate E; Chyou, Te-Yuan; Nishtala, Prasad S
組織名	Department of Pharmacy and Pharmacology, University of Bath, Bath, BA2 7AY, UK.;Department of Biochemistry, University of Otago, Dunedin, New Zealand.;p.nishtala@bath.ac.uk.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32248429/

タグ:

お問合わせ

キーワード